Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus

NCT02683746 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

308

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Lyophilized albiglutide DCC pen injector
DRUG: Lyophilized albiglutide DCC pen injector matching placebo
DRUG: Albiglutide liquid auto-injector
DRUG: Albiglutide liquid auto-injector matching placebo

Sponsor

GlaxoSmithKline